{
  "resourceType": "MedicinalProductDefinition",
  "id": "DZPorifarm-5mg-Tablet-SE-IS-MedicinalProductDefinition",
  "meta": {
    "profile": [
      "http://unicom-project.eu/fhir/StructureDefinition/PPLMedicinalProductDefinition"
    ]
  },
  "identifier": [
    {
      "system": "http://ema.europa.eu/fhir/mpId",
      "value": "SE-100002342-00057369"
    },
    {
      "system": "http://ema.europa.eu/fhir/eurdId",
      "value": "1029"
    }
  ],
  "combinedPharmaceuticalDoseForm": {
    "coding": [
      {
        "code": "100000073664",
        "system": "https://spor.ema.europa.eu/v1/lists/200000000004",
        "display": "Tablet"
      }
    ]
  },
  "domain": {
    "coding": [
      {
        "code": "100000000012",
        "system": "https://spor.ema.europa.eu/v1/lists/100000000004",
        "display": "Human use"
      }
    ]
  },
  "status": {
    "coding": [
      {
        "code": "200000005004",
        "system": "https://spor.ema.europa.eu/v1/lists/200000005003",
        "display": "Current"
      }
    ]
  },
  "indication": "Diazepam påverkar de vid ångestsyndrom vanliga symtomen ängslan, ångest, rastlöshet och  därav följande sömnsvårigheter. Vid depressioner med inslag av nämnda symtom kan  Diazepam Orifarm ges i kombination med antidepressiva farmaka.  Delirium tremens, predeliriösa tillstånd och akuta abstinenssymtom i samband med  alkoholmissbruk.  Cerebralt och perifert betingade muskelspasmer.  Premedicinering. ",
  "legalStatusOfSupply": {
    "coding": [
      {
        "code": "100000072085",
        "system": "https://spor.ema.europa.eu/v1/lists/100000072051",
        "display": "Medicinal product subject to special medical prescription"
      }
    ]
  },
  "classification": [
    {
      "coding": [
        {
          "code": "100000093533",
          "system": "https://spor.ema.europa.eu/v1/lists/100000116677",
          "display": "N05BA01"
        }
      ]
    }
  ],
  "name": [
    {
      "productName": "Diazepam Orifarm 5 mg Tablett"
    }
  ]
}
